Natco Pharma has received final USFDA approval for generic Armodafinil tablets, used as wakefulness promoting agent. The company plans to market the same in US in the strengths of 50 mg, 150 mg and 250 mg. Cephalon sells the product in three strengths under the brand name Nuvugil, it added. According to IMS health, Nuvugil tablets had US sales of around USD 480 million for twelve months ending December 2015
Company Profile : Natco Pharma Ltd
Leave a Reply